Document is current
Any future updates will be listed below
-
Authors
Zarbock, Alexander https://orcid.org/0000-0002-2124-1714
Legrand, Matthieu
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (ZA 428/30-1)
Deutsche Forschungsgemeinschaft (ZA 428/29-1)
Deutsche Forschungsgemeinschaft (ZA 428/21-1)
Universitätsklinikum Münster
- License Information
-
More Information
Article History
Received: 18 September 2025
Accepted: 26 October 2025
First Online: 3 November 2025
Declarations
:
: AZ has received lecture and consultancy fees from Baxter, Fresenius, BioMerieux, Viatris, Guard Therapeutics, Novartis, Paion, AM Pharma, Alexion, Renibus, and Bayer as well as an unrestricted research grants from Baxter and BioMerieux. ML received personal fees from Viatris, Alexion, Idorsia, Vantive, and Radiometer.
: Not applicable.
